DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced ...
Despite efforts by the United States and allied governments, China's appetite for foreign technology and use of extraordinary means to obtain it has not diminished.